AME GA Approves SAR 14 Mln Dividend for 2024, Reject BOD Article Amendment

AME Company for Medical Supplies announced on Monday the results of its Extraordinary General Assembly Meeting (First Meeting). The voting results were as follows:

1.            Rejecting the amendment to Article No. (12) of the Company’s Articles of Association, related to (Board of Directors Management);

2.            Approving the amendment to Article Nineteen of the Company’s Articles of Association, related to the quorum for Board of Directors meetings;

3.            Reviewing the Board of Directors’ report for the fiscal year ending December 31, 2024;

4.            Reviewing the financial statements for the fiscal year ending December 31, 2024;

5.            Approval of the Company’s Auditor’s Report for the fiscal year ending December 31, 2024;

6.            Approval of the termination of the contract with the Company’s current auditor, due to the auditor having exhausted the maximum permitted statutory period, in accordance with Article 3 of the Executive Regulations of the Companies Law issued by the Capital Market Authority regarding listed joint-stock companies;

7.            Approval of the selection of Ernst & Young as the Company’s auditor from among the candidates, based on the Audit Committee’s recommendation, to examine, review, and audit the financial statements for the second and third quarters and annual period of fiscal year 2025, and for the first, second, and third quarters and annual period of fiscal years 2026 and 2027, and to determine their fees;

8.            Approval of the discharge of the Board of Directors from liability for the fiscal year 2024;

9.            Approval of the premature termination of the current Board of Directors’ term on July 30, 2025;

10.         Approval of the Board of Directors’ recommendation to distribute cash dividends in the amount of (14,000,000) (fourteen million) riyals to shareholders for the financial period ending on December 31, 2024, at a rate of (2) (two) riyals per share, representing (20%) of the capital. Eligibility shall be for shareholders who own shares at the end of trading on the day of the General Assembly Meeting and are registered in the company’s shareholders’ register with the Securities Depository Centre Company (Depository Centre) at the end of the second trading day following the due date. Dividends will be disbursed to the accounts associated with the portfolios of eligible shareholders, effective from June 11, 2025;

11.         Approval of the disbursement of an amount of 660,000 riyals as remuneration to members of the Board of Directors for the fiscal year ending on December 31, 2024;

12.         Approval of the amendment to the Board of Directors’ Remuneration Policy; and

13.         Approval of the Policy on Standards and Procedures for Nomination to Board Membership.